Literature DB >> 34279724

Molecular mechanisms of pancreatic myofibroblast activation in chronic pancreatitis and pancreatic ductal adenocarcinoma.

Andrew Cannon1, Christopher Michael Thompson1, Rakesh Bhatia1, Katharine Anne Armstrong2, Joyce Christopher Solheim3,4, Sushil Kumar5, Surinder Kumar Batra6,7,8.   

Abstract

Pancreatic fibrosis (PF) is an essential component of the pathobiology of chronic pancreatitis (CP) and pancreatic ductal adenocarcinoma (PDAC). Activated pancreatic myofibroblasts (PMFs) are crucial for the deposition of the extracellular matrix, and fibrotic reaction in response to sustained signaling. Consequently, understanding of the molecular mechanisms of PMF activation is not only critical for understanding CP and PDAC biology but is also a fertile area of research for the development of novel therapeutic strategies for pancreatic pathologies. This review analyzes the key signaling events that drive PMF activation including, initiating signals from transforming growth factor-β1, platelet derived growth factor, as well as other microenvironmental cues, like hypoxia and extracellular matrix rigidity. Further, we discussed the intracellular signal events contributing to PMF activation, and crosstalk with different components of tumor microenvironment. Additionally, association of epidemiologically established risk factors for CP and PDAC, like alcohol intake, tobacco exposure, and metabolic factors with PMF activation, is discussed to comprehend the role of lifestyle factors on pancreatic pathologies. Overall, this analysis provides insight into the biology of PMF activation and highlights salient features of this process, which offer promising therapeutic targets.
© 2021. Japanese Society of Gastroenterology.

Entities:  

Keywords:  Cell signaling; Chronic pancreatitis; Myofibroblast; Pancreatic cancer; Pancreatic fibrosis

Mesh:

Year:  2021        PMID: 34279724      PMCID: PMC9052363          DOI: 10.1007/s00535-021-01800-4

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   6.772


  149 in total

1.  Effects of angiotensin II receptor antagonist, Losartan on the apoptosis, proliferation and migration of the human pancreatic stellate cells.

Authors:  Wen-Bin Liu; Xing-Peng Wang; Kai Wu; Ru-Ling Zhang
Journal:  World J Gastroenterol       Date:  2005-11-07       Impact factor: 5.742

Review 2.  Families of retinoid dehydrogenases regulating vitamin A function: production of visual pigment and retinoic acid.

Authors:  G Duester
Journal:  Eur J Biochem       Date:  2000-07

3.  A c-Jun NH2-terminal kinase inhibitor SP600125 (anthra[1,9-cd]pyrazole-6 (2H)-one) blocks activation of pancreatic stellate cells.

Authors:  Atsushi Masamune; Kazuhiro Kikuta; Noriaki Suzuki; Masahiro Satoh; Kennichi Satoh; Tooru Shimosegawa
Journal:  J Pharmacol Exp Ther       Date:  2004-03-31       Impact factor: 4.030

4.  NADPH oxidase plays a crucial role in the activation of pancreatic stellate cells.

Authors:  Atsushi Masamune; Takashi Watanabe; Kazuhiro Kikuta; Kennichi Satoh; Tooru Shimosegawa
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-10-25       Impact factor: 4.052

5.  Protection of cerulein-induced pancreatic fibrosis by pancreas-specific expression of Smad7.

Authors:  Jing He; Xiaolan Sun; Ke-Qing Qian; Xubao Liu; Zhenzhen Wang; Yan Chen
Journal:  Biochim Biophys Acta       Date:  2008-10-30

6.  Effects of angiotensin II on rat pancreatic stellate cells.

Authors:  Roland Reinehr; Stefan Zoller; Hanne Klonowski-Stumpe; Claus Kordes; Dieter Häussinger
Journal:  Pancreas       Date:  2004-03       Impact factor: 3.327

7.  Nicotine promotes activation of human pancreatic stellate cells through inducing autophagy via α7nAChR-mediated JAK2/STAT3 signaling pathway.

Authors:  Zhiren Li; Xiaoyun Zhang; Tong Jin; Jianyu Hao
Journal:  Life Sci       Date:  2020-01-14       Impact factor: 5.037

8.  Monocytes infiltrate the pancreas via the MCP-1/CCR2 pathway and differentiate into stellate cells.

Authors:  Kazuko Ino; Masahiro Masuya; Isao Tawara; Eri Miyata; Keiko Oda; Yoshiki Nakamori; Kei Suzuki; Kohshi Ohishi; Naoyuki Katayama
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

9.  Role of bone marrow-derived cells in experimental chronic pancreatitis.

Authors:  F Marrache; S Pendyala; G Bhagat; K S Betz; Z Song; T C Wang
Journal:  Gut       Date:  2008-03-26       Impact factor: 31.793

10.  Protonation of Piezo1 Impairs Cell-Matrix Interactions of Pancreatic Stellate Cells.

Authors:  Anna Kuntze; Ole Goetsch; Benedikt Fels; Karolina Najder; Andreas Unger; Marianne Wilhelmi; Sarah Sargin; Sandra Schimmelpfennig; Ilka Neumann; Albrecht Schwab; Zoltan Pethő
Journal:  Front Physiol       Date:  2020-02-14       Impact factor: 4.566

View more
  3 in total

Review 1.  The Desmoplastic Stroma of Pancreatic Cancer: Multilayered Levels of Heterogeneity, Clinical Significance, and Therapeutic Opportunities.

Authors:  Yohei Masugi
Journal:  Cancers (Basel)       Date:  2022-07-05       Impact factor: 6.575

Review 2.  NOX4: a potential therapeutic target for pancreatic cancer and its mechanism.

Authors:  Yawei Bi; Xiao Lei; Ningli Chai; Enqiang Linghu
Journal:  J Transl Med       Date:  2021-12-20       Impact factor: 5.531

3.  Keratin 8 Is an Inflammation-Induced and Prognosis-Related Marker for Pancreatic Adenocarcinoma.

Authors:  Fei Xiong; Tong Guo; Xin Wang; Guanhua Wu; Wenzheng Liu; Qi Wang; Bing Wang; Yongjun Chen
Journal:  Dis Markers       Date:  2022-07-27       Impact factor: 3.464

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.